Sort by
Performance of an amine-based CO2 capture pilot plant at the Fortum Oslo Varme Waste to Energy plant in Oslo, Norway

Fortum Oslo Varme AS (FOV) decided (in July 2018) to build a 1:350 scale pilot plant to demonstrate that the selected Shell’s CANSOLV capture technology using solvent DC-103 is suitable for cleaning CO₂ from the exhaust gases of their waste to energy (WtE) plant at Klemetsrud in Oslo, Norway. This paper presents the most important measurement data and results from a pilot plant testing campaign from March to December 2019.The project stated requirements for the successful completion of the first pilot plant campaign were at least 2000 operational hours and total amine emissions lower than 0.4 ppmv on average over the last 500 h of testing. Emphasis is on the online emission measurement results both with and without an aerosol emissions mitigation system located downstream of the capture unit. The impact of perturbations in the plant operating conditions and inlet gas quality is discussed, in particular the particulates content.The pilot plant campaign achieved its primary purpose of demonstrating low amine emissions. It also produced important data on absorbent degradation in actual operation on WtE flue gas while confirming other performance parameters such as CO2 capture efficiency, steam consumption and CO2 product purity. Thus, it can be concluded that the all requirements according to objectives of the pilot campaign were successfully met.

Open Access
Relevant
Evaluating patient experiences in decentralised acute care using the Picker Patient Experience Questionnaire; methodological and clinical findings

BackgroundDecentralised acute care services have, through the establishment of municipality acute wards (MAWs), been launched in Norway. The aim is to provide treatment for patients who otherwise would need hospitalisation. Currently there is a lack of studies investigating patient experiences in such services. The aims of this study were therefore to a) translate and validate the Picker Patient Experience Questionnaire (PPE-15) in Norwegian, and b) assess patient experiences in decentralised acute care, and potential factors associated with these experiences.MethodsPatients were recruited from five municipal acute wards in southeastern Norway during the period from June 2014 to June 2015. Data on socio-demographics, length of stay and comorbidity (Charlson comorbidity index (CCI)) were collected. Patients completed the Picker Patient Experience Questionnaire (PPE-15) and the EuroQOL 5-dimension, 3-level version. Convergent validity of the PPE-15 was assessed by correlation of items in PPE-15 and the Nordic Patient Experience Questionnaire (NORPEQ). A retest of the PPE-15 was performed in a subgroup of patients approximately 3 weeks after baseline assessment. Test-retest agreement was assessed with Cohens’ unweighted Kappa.ResultsA total of 479 patients responded, median age 78.0 years and 41.8% men. A total of 68 patients participated in the retest. Testing of convergent validity revealed an overall weak to moderate correlation. Kappa statistics showed from fair to good test-retest agreement. Most problems were related to continuity and transition, while fewest problems were related to respect for patient preferences. A higher Charlson comorbidity score was the only variable that was negatively associated with patient experience.ConclusionPatients reported problems in several items of the PPE-15 after discharge from decentralised acute wards. The findings from the current study may be helpful for planning ways to improve quality of care, e.g., by providing feedback to healthcare personnel or by using patient experience as a quality indicator.

Open Access
Relevant